| Pharmaceutical active ingredients: |
| Flunisolide |
| Available forms, composition and doses of Rhinalar: |
| Spray; Nasal; Flunisolide 0.025% |
| Rhinalar medical category: |
| Human:Anti-inflammatory agentsCorticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AD04 - FlunisolideR03BA03 - Flunisolide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheSyntex |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Repilysin | Reteplase | Roche |
| Restex | Benserazide Hydrochloride; Levodopa | Roche |
| Retavase | Reteplase; Water | Roche; Biovail Pharmaceuticals; Centocor; EKR Therapeutics; PDL Biopharma |
| Rexitene | Guanabenz Acetate | Roche; LPB Istituto Farmaceutico |
| Rexitene Plus | Guanabenz Acetate; Mefruside | Roche; LPB Istituto Farmaceutico |
| Rhino-Tantum | Benzydamine Hydrochloride | Roche |
| Rimifon | Isoniazid | Roche; Cambridge Laboratories; Celgene; Labatec Pharma; Laphal Industrie; Pharmion |
| Rinobanedif | Bacitracin Zinc; Cineole; Neomycin Sulfate; Niaouli Oil; Phenylephrine Hydrochloride; Prednisolone | Roche |
| Rinodif | Oxymetazoline Hydrochloride | Roche |
| Rinotiazol Fenilefri | Atropine Sulfate; Cineole; Niaouli Oil; Phenylephrine Hydrochloride; Sulfathiazole | Roche |